253 related articles for article (PubMed ID: 7246612)
1. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
[TBL] [Abstract][Full Text] [Related]
2. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
[TBL] [Abstract][Full Text] [Related]
3. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
[TBL] [Abstract][Full Text] [Related]
4. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
[TBL] [Abstract][Full Text] [Related]
5. Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.
Percy ME; Andrews DF; Brasher PM; Rusk AC
Am J Med Genet; 1987 Apr; 26(4):851-61. PubMed ID: 3591827
[TBL] [Abstract][Full Text] [Related]
6. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
[TBL] [Abstract][Full Text] [Related]
9. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
10. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
11. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
12. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
[TBL] [Abstract][Full Text] [Related]
13. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing.
Percy ME; Andrews DF; Thompson MW
Muscle Nerve; 1982 Jan; 5(1):58-64. PubMed ID: 7057807
[TBL] [Abstract][Full Text] [Related]
14. Serum myoglobin in muscular dystrophy.
Kagen LJ; Moussavi S; Miller SL; Tsairis P
Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
[TBL] [Abstract][Full Text] [Related]
15. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
Zatz M; Karp LE; Rogatko A
Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
[TBL] [Abstract][Full Text] [Related]
17. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
Ionasescu V; Burmeister L; Hanson J
Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
[TBL] [Abstract][Full Text] [Related]
18. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
[TBL] [Abstract][Full Text] [Related]
19. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
[TBL] [Abstract][Full Text] [Related]
20. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]